R2 Companies

Investorcompany

Member since October 2024

$163M

Volume

$163M

Sold

—

Financed

$2M

Leased

Closed

2M sf

Area

AI SummaryBeta

R2 Companies focuses on office investments, recently closing 14 deals totaling $163M in volume. Their notable transactions include acquiring two office buildings in Chicago for $12 million and expanding Takeda Pharmaceuticals' lease by 80,000 square feet.

AI-generated from Traded deal data. May contain errors.

No bio available yet

This broker hasn't added a bio to their profile yet. Check back later for more details about their background and expertise.

Top Deals

SOLD

Share this deal

Open in a new tab

Redline Property Partners Acquires Historic 15 Building In Minneapolis From Goldman Sachs & R2 Companies

Minnesota | Office

07/15/2026

SOLD

Share this deal

Open in a new tab

R2 Companies To Acquire 41-Story Tower At 150 North Michigan Avenue In Chicago For $70M

Illinois | Office | PPSF: $105

06/23/2023

SOLD

Share this deal

Open in a new tab

Matt Garrison Of R2 Companies Acquires Office Building At 600 West Fulton Street For $17.6M

Illinois | Office | PPSF: $81

07/06/2026

SOLD

Share this deal

Open in a new tab

Keith Jacobs Of Generation 4 And Brian Hoffman Of Red Seal Homes Acquire 19.4 Acres In Glenview For $14M

Illinois | Office

01/05/2026

SOLD

Share this deal

Open in a new tab

Matt Garrison & Peter Remes Acquire Mixed-Use Asset In Saint Paul For $12.3M

Minnesota | Mixed-use | PPSF: $24

11/13/2025

Focus

Mixed-use

Sale

Markets

FAQs

R2 Companies has financed 5 deals.

R2 Companies's most recent deal was on January 26, 2026.

R2 Companies's largest deals include a sale of $70,000,000.00 for 150 N Michigan Ave, Chicago, IL 60601, USA, and a lease covering 8,587 sqft for 130 S Jefferson St Chicago, Il 60661, Usa.